# DOCETAXEL

NDC: 16729-267
Generic name: docetaxel
Labeler / Manufacturer: Accord Healthcare Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20130530

FDA application: NDA201195

## Active ingredients

- DOCETAXEL ANHYDROUS: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16729-267"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16729-267
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f59f7811-70b7-4c44-99f7-4f4fdce3ed22